(Q54547311)
Statements
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo. (English)
M M Vickers
E D Powell
T R Asmis
D J Jonker
J F Hilton
C J O'Callaghan
D Tu
W Parulekar
M J Moore
24 November 2011
48
10
1434-1442